Meeting Abstract
Autorenliste: Fenk, Roland; Baier, Julia; Giagounidis, Aristoteles; Rummel, Mathias J.; Kroeger, Nicolaus; Strapatsas, Tobias; Dienst, Ariane; Zipperer, Esther; Nachtkamp, Kathrin; Burchardt, Alexander; Schroeder, Thomas; Galonska, Lars; Gattermann, Norbert; Haas, Rainer; Kobbe, Guido
Jahr der Veröffentlichung: 2012
Zeitschrift: Blood
Bandnummer: 120
Heftnummer: 21
ISSN: 0006-4971
eISSN: 1528-0020
DOI Link: https://doi.org/10.1182/blood.V120.21.1982.1982
Konferenz: 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)
Verlag: American Society of Hematology (ASH Publications)
Zitierstile
Harvard-Zitierstil: Fenk, R., Baier, J., Giagounidis, A., Rummel, M., Kroeger, N., Strapatsas, T., et al. (2012) Safety and Efficacy of a Six Month Full Dose Lenalidomide Consolidation Treatment After First-Line High-Dose Therapy in Patients with Multiple Myeloma, Blood, 120(21). https://doi.org/10.1182/blood.V120.21.1982.1982
APA-Zitierstil: Fenk, R., Baier, J., Giagounidis, A., Rummel, M., Kroeger, N., Strapatsas, T., Dienst, A., Zipperer, E., Nachtkamp, K., Burchardt, A., Schroeder, T., Galonska, L., Gattermann, N., Haas, R., & Kobbe, G. (2012). Safety and Efficacy of a Six Month Full Dose Lenalidomide Consolidation Treatment After First-Line High-Dose Therapy in Patients with Multiple Myeloma. Blood. 120(21). https://doi.org/10.1182/blood.V120.21.1982.1982
